![]() |
市場調查報告書
商品編碼
1292531
全球上肢植入物市場規模、份額、行業趨勢分析報告按材料、類型(肩部、肘部、手/腕部)、用途、區域展望和預測,2023-2029Global Upper Extremity Implants Market Size, Share & Industry Trends Analysis Report By Material, By Type (Shoulder, Elbow and Hand & Wrist), By End-use (Hospitals, Clinics and ASCs'), By Regional Outlook and Forecast, 2023 - 2029 |
預計到 2029 年,上肢植入物的市場規模將達到 23 億美元,預測期內復合年增長率為 6.2%。
根據 KBV 基數矩陣中的分析,DePuy Synthes (Johnson &Johnson) 是該市場的領導者。 2021年10月,DePuy Synthes推出了2.7mm鎖骨接骨板系統“可變角度鎖定加壓接骨板”,用於治療小、中、大外側、軸向和內側鎖骨骨折。 該推出的產品提供了一種將鎖骨尺寸與患者身高相關聯的板形狀,符合鎖骨的弓形和輪廓,並包括廣泛的鎖骨解剖變異性。 Medtronic PLC、Stryker Corporation 和 Zimmer Biomet Holdings, Inc. 等公司是該市場的主要創新者。
市場增長因素
運動損傷增加
全年參加某些體育運動是導致傷害增加的一個主要原因,尤其是在年輕人中。 如今,許多運動員選擇專攻並專注於一項運動。 因此,如今,即使是輕微的肌肉不平衡和功能障礙也更有可能導致過度使用損傷。 此外,18歲以下的運動員受傷的情況也更多。 即使您正在開展各種預防活動,也可能很難將其付諸實踐。 因此,與運動相關的傷害正在增加,特別是在年輕人中,這預計將增加對上肢植入物的需求並支持市場擴張。
老年人口增加
人口老齡化,或者說年齡分佈的老齡化,主要出現在高收入國家。 然而,這一趨勢對低收入和中等收入國家的影響最大。 例如,在日本,超過60%的人口年齡在30歲以上。 到 2050 年,大多數 60 歲以上的人口預計將生活在低收入和中等收入國家。 由於平均壽命的延長,老齡化社會正在進步。 而老年人更容易出現肌肉和關節相關並發症,可能需要上肢等植入物,預計這將推動市場增長。
市場抑制因素
種植手術後的並發症
所有外科手術都存在一定的風險,而傳染性感染的存在可能會加劇這些風險。 感染、失血和脫臼風險是關節置換手術的三大風險。 種植體脫位是當種植體周圍的肌肉變弱時(尤其是在治療後的前三個月)運動不當可能導致的問題。 為了防止這個問題,重要的是避免某些活動,尤其是手術後的前三個月。 這可能會阻礙上肢植入物的市場增長。
輸入 Outlook
按類型劃分,市場分為肩部、肘部和手/手腕。 肩部部分將在 2022 年市場中佔據最高的收入份額。 這是因為,由於運動損傷、肩關節脫位、人口老齡化、骨關節炎病例增加、肩關節骨折等增加,對上肢植入物的產品需求不斷增加。 肩關節置換術是最常見的四肢骨科手術之一。
材料展望
按材料分類,生物材料可分為金屬生物材料、陶瓷生物材料、高分子生物材料和天然生物材料。 天然生物材料領域在 2022 年市場取得了大幅增長。 天然生物材料在外科手術中普遍存在。 此外,這種生物材料支架或支持物使細胞能夠開始構建新組織,從而在預測期內推動該細分市場的增長。
最終使用 Outlook
按最終用途,可分為醫院、ASC 和診所。 ASC 細分市場在 2022 年市場取得了可喜的增長率。 這是由於上肢手術對 ASC 的需求不斷增加、新產品不斷進步以及 FDA 的批准。 憑藉出色的術後疼痛管理、患者提早出院、副作用更少以及總體成本最小化,ASC 類別為患者帶來了額外的好處。 預計這些因素將推動該細分市場的增長。
區域展望
按地區劃分,在北美、歐洲、亞太地區和拉美地區進行了分析。 2022 年,北美地區將佔據最高的市場收入份額。 這是由於肩部損傷增加,包括骨折、扭傷、拉傷、脫臼和分離等因素造成的。 此外,北美地區重要參與者的存在以及運動損傷的增加正在推動區域擴張。 此外,隨著治療骨折、脫臼、肌腱炎、關節炎等各種疾病的醫療機構的建立,對產品的需求顯著增加,推動了該地區的市場增長。
The Global Upper Extremity Implants Market size is expected to reach $2.3 billion by 2029, rising at a market growth of 6.2% CAGR during the forecast period.
Natural Biomaterials is gaining popularity and growing at a faster rate because of its capacity for integrating and modifying as well as their bio-compatibility with the patient's tissue. Therefore, Natural Biomaterials registered $157.8 million revenue in 2022. According to a recent analysis of Global Burden of Disease (GBD) 2019 statistics, 1.71 billion people worldwide are affected by musculoskeletal diseases such as fractures, osteoarthritis, amputation and other injuries, and arthritis. Most affected are 441 million in high-income countries, 427 million in the WHO Western Pacific Region, and 369 million in the WHO South-East Asia Region. In addition, musculoskeletal diseases are the leading cause of YLDs, accounting for more than 149 million YLDs, or 17 percent of all YLDs globally.
The major strategies followed by the market participants are Acquisitions as the key developmental strategy in order to keep pace with the changing demands of end users. For instance, In November, 2020, Stryker acquired Wright Medical Group N.V. to innovate and reach more patients. Additionally, In May, 2023, Zimmer Biomet took over Ossis to build out their partnership and broadening Zimmer Biomet's orthopedic suite with the addition of Ossis' personalized implants. Together with this, Zimmer Biomet Holdings, Inc. acquired Embody, Inc. in February, 2023, to strengthen its growing Sports Medicine suite and supports continued business transformation.
Based on the Analysis presented in the KBV Cardinal matrix; DePuy Synthes (Johnson & Johnson) is the forerunner in the Market. In October, 2021, DePuy Synthes introduced Variable Angle Locking Compression Plate, a 2.7 mm Clavicle Plate System, for the treatment of lateral, shaft and medial fractures for small, medium and large clavicles. The launched product provides plate shapes that show the correlation between clavicle size and patient stature to match the bow and contour of the clavicle and contain a wide range of anatomic variability of the clavicle. Companies such as Medtronic PLC, Stryker Corporation and Zimmer Biomet Holdings, Inc. are some of the key innovators in Market.
Market Growth Factors
The increasing prevalence of sport injuries
The leading cause of the increase in injuries, especially in young people, is the year-round participation in a particular sport. Nowadays, many athletes opt to specialize in and focus on just one sport. So today, a slight muscle imbalance or dysfunction is far more likely to lead to an overuse injury. Also, athletes under the age of 18 are suffering more injuries, even though they engage in various preventative activities, putting it into action could be difficult. Thus, for these reasons, sports-related injuries are becoming more common, particularly in young people, which is predicted to drive up demand and support market expansion.
The growing number of older adults
Population aging, or a country's movement in age distribution toward older ages, has been seen mostly in high-income nations. However, this trend has the biggest influence in low- and middle-income countries. For instance, the population of Japan is over 60% older than the age of 30. Most people over 60 are expected to live in low- and middle-income countries by 2050. An aging population is on the rise due to increased life expectancy. And as older populations are more prone to muscle or joints related complications, which may require implants like upper extremities, implants are expected to drive the market growth.
Market Restraining Factors
Complications following implant surgery
Every surgical operation has some risks; the existence of contagious infections can make these risks worse. The danger of infection, blood effusion, and dislocation are the three main risks associated with joint replacement surgery. Dislocation of the implant is a problem that can happen during an inappropriate movement when the muscles surrounding the implant are too weak (particularly in the first three months following the treatment). Avoiding specific motions is crucial to preventing this problem, especially in the first three months following the operation. This will hinder the market growth for upper extremities implants.
Type Outlook
Based on type, the market is segmented into shoulder, elbow and hand & wrist. The shoulder segment held the highest revenue share in the market in 2022. This is due to the increase in sports injuries, shoulder dislocations, an aging population, a growth in osteoarthritis cases, and shoulder fractures, resulting in a rise in demand for products for implanting the upper extremities. In addition, shoulder replacements rank among the most common orthopedic operations for the extremities.
Material Outlook
On the basis of material, the market is divided into metallic biomaterials, ceramic biomaterials, polymeric biomaterials and natural biomaterials. The natural biomaterials segment procured a considerable growth rate in the market in 2022. Natural biomaterials have become popular in surgical operations. Also, this biomaterial's scaffolding or support enables cells to begin building new tissue, which provides the segment's growth in the forecasted period.
End-Use Outlook
By end-use, the market is classified into hospitals, ASCs' and clinics. The ASCs' segment garnered a promising growth rate in the market in 2022. This is due to increased demand for ASCs in upper-extremities procedures, increased new product advancements, and FDA approval. With excellent postoperative pain management, quick patient discharge, few side effects, and overall cost minimization, the ASCs category offers additional benefits to the patient. The above-mentioned factors are anticipated to drive the market segment's growth.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the market in 2022. This is owing to factors like the increase in shoulder injuries, including fractures, sprains, and strains, as well as dislocations and separations. In addition, the presence of important participants in North America and the rise in sports injuries are driving regional expansion. Also, the need for products has grown significantly as a result of the establishment of healthcare facilities that treat a variety of ailments, such as fractures, dislocations, tendonitis, and arthritis, which is fueling the market growth in the region.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, DePuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, Medtronic PLC, Aesculap, Inc. (B. Braun Melsungen AG), DJO Global (Enovis Corporation), Ossur Hf., Acumed LLC (Colson Medical, Inc.) and Arthrex, Inc.
Recent Strategies Deployed in Upper Extremity Implants Market
Partnerships, Collaborations and Agreements:
May-2023: Zimmer Biomet took over Ossis, a maker 3D-printed orthopaedic implant. This acquisition would aim to build out their partnership and broadening Zimmer Biomet's orthopedic suite with the addition of Ossis' personalized implants.
Feb-2023: Zimmer Biomet Holdings, Inc. acquired Embody, Inc., a medical device company focused on soft tissue healing. Under this acquisition, Zimmer Biomet strengthens its growing Sports Medicine suite and supports continued business transformation.
Jul-2022: Acumed acquired ExsoMed, a provider of advanced solutions for hand surgery. This acquisition of ExsoMed, whose products support an intramedullary approach to treat hand fractures, increase Acumed's complete suite of upper extremity solutions for easy to complex injuries.
Jan-2021: DJO, LLC completed the acquisition of Trilliant Surgical®, a national provider of foot and ankle orthopedic implants. Following this acquisition, Trilliant Surgical's major product technologies and clinical efficacy supports DJO's focused development into the adjacent high-growth US foot and ankle market.
Jan-2021: Smith+Nephew completed the acquisition of the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation, a provider of broader and deeper solutions with an extensive soft tissue reconstruction offering. This acquisition would support Smith+Nephew's strategy to invest in higher growth segments. This would notably strengthen Smith+Nephew's extremities business by adding a combination of a focused sales channel, aligning with shoulder replacement and upper and lower extremities suite.
Product Launches and Product Expansions:
Oct-2021: DePuy Synthes introduced Variable Angle Locking Compression Plate, a 2.7 mm Clavicle Plate System, for the treatment of lateral, shaft and medial fractures for small, medium and large clavicles. The launched product provides plate shapes that shows the corelation between clavicle size and patient stature to match the bow and contour of the clavicle and contain a wide range of anatomic variability of the clavicle.
Aug-2021: Johnson & Johnson's DePuy Synthes division announced the launch of the Inhance shoulder system, a fully integrated system that includes both stemmed and stemless implants. The launch enables the surgeon to easily transform from the former to the latter at the time of procedure if required. Additionally, the product is designed to tackle a wide range of cases.
Geographical Expansions:
Jan-2022: Medtronic plc received a Japan's Ministry of Health, Labour and Welfare for the sale and reimbursement approval of the Micra™ AV Transcatheter Pacing System. This approval broadens the number of patients across Japan eligible to receive Micra TPS, the world's smallest pacemaker.
Approvals and Trials:
Aug-2022: Stryker opened a new facility in Ireland. The new high-tech facility is a 156,000-square-foot facility, which would reinforce the company's market position in additive manufacturing.
Market Segments covered in the Report:
By Material
By Type
By End-use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures